United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

healthcare pharma ltd - pyridoxine hydrochloride - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zanza specials international ltd - pyridoxine hydrochloride - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - pyridoxine hydrochloride - oral tablet - 50mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

yerevan chemical-pharmaceutical firm ojsc - pyridoxine (pyridoxine hydrochloride) - solution for i/m, i/v and s/c injection - 50mg/ml

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - pyridoxine hydrochloride injection is effective for the treatment of pyridoxine deficiency as seen in the following:      inadequate dietary intake.      drug-induced deficiency, as from isoniazid (inh) or oral contraceptives. inborn errors of metabolism, e.g., vitamin b 6 dependent convulsions or vitamin b 6 responsive anemia. the parenteral route is indicated when oral administration is not feasible as in anorexia, nausea and vomiting, and preoperative and postoperative conditions.  it is also indicated when gastrointestinal absorption is impaired. a history of sensitivity to pyridoxine or to any of the ingredients in pyridoxine hydrochloride injection, usp is a contraindication. symptoms of dependence have been noted in adults given only 200

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - pyridoxine hydrochloride injection is effective for the treatment of pyridoxine deficiency as seen in the following: inadequate dietary intake. drug-induced deficiency, as from isoniazid (inh) or oral contraceptives. inborn errors of metabolism, e.g., vitamin b6 dependent convulsions or vitamin b6 responsive anemia. the parenteral route is indicated when oral administration is not feasible as in anorexia, nausea and vomiting, and preoperative and postoperative conditions. it is also indicated when gastrointestinal absorption is impaired. a history of sensitivity to pyridoxine or to any of the ingredients in pyridoxine hydrochloride injection, usp is a contraindication. symptoms of dependence have been noted in adults given only 200 mg daily, followed by withdrawal.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eumedica sa-nv - pyridoxine hydrochloride 250 mg - tablet - 250 mg - pyridoxine hydrochloride 250 mg - pyridoxine (vit b6)

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

yerevan chemical-pharmaceutical firm ojsc - pyridoxine (pyridoxine hydrochloride) - solution for i/m, i/v and s/c injection - 50mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - pyridoxine hydrochloride 50mg (+1.8% (0.9mg) overage);  ;  ;   - tablet - 50 mg - active: pyridoxine hydrochloride 50mg (+1.8% (0.9mg) overage)       excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose

Kenya - English - Pharmacy and Poisons Board

universal corporation limited p.o box 1748-00902, kikuyu,kenya - pyridoxine hydrochloride - tablet - each tablet contains pyridoxine 50mg - other plain vitamin preparations